HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The possibilities of using the newest experimental results in the progressive myopia treatment].

Abstract
Most recent experimental results concerning the pathomechanism of myopia are discussed. Anatomical, physiological, and biochemical changes taking place in the eye with experimental myopia are described. Special attention is focused on the following substances inhibiting the progress of experimental myopia: apomorphine, reserpine, 6-hydroxydopamine, atropine, pirenzepine, chlorpyrifos, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid, kainic acid, naloxane, formoguanamine, gentamicin, sodium iodate, central and peripheral antagonist of vasoactive intestinal polypeptide, basic fibroblast growth factor. The possibilities of the above-mentioned pharmacological agents in the progressive myopia treatment are indicated.
AuthorsD Czepita
JournalKlinika oczna (Klin Oczna) Vol. 101 Issue 2 Pg. 145-7 ( 1999) ISSN: 0023-2157 [Print] Poland
Vernacular TitleMozliwości wykorzystania wyników najnowszych badań doświadczalnych w leczeniu krótkowzroczności postepujacej.
PMID10418242 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Animals
  • Combined Modality Therapy
  • Disease Progression
  • Health Services (trends)
  • Humans
  • Myopia (etiology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: